Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,144.30
    +65.44 (+0.81%)
     
  • Bitcoin USD

    63,998.16
    +578.54 (+0.91%)
     
  • CMC Crypto 200

    1,340.49
    -56.04 (-4.01%)
     
  • S&P 500

    5,098.67
    +50.25 (+1.00%)
     
  • Dow

    38,182.21
    +96.41 (+0.25%)
     
  • Nasdaq

    15,917.01
    +305.25 (+1.96%)
     
  • Gold

    2,345.60
    +3.10 (+0.13%)
     
  • Crude Oil

    83.38
    -0.19 (-0.23%)
     
  • 10-Yr Bond

    4.6530
    -0.0530 (-1.13%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win

These 2 Pharma Stocks Might Face Off Soon -- but They Could Both Win

Eli Lilly (NYSE: LLY) and Biogen (NASDAQ: BIIB) are both keen to compete in the market for Alzheimer's disease therapies. Biogen's prior attempt at an Alzheimer's medicine to hit the market was a train wreck, but its latest drug seems to be avoiding a repeat. Meanwhile, Eli Lilly has yet to submit its candidate for regulatory review.